Article thumbnail

mRNA Levels in Control Rat Liver Display Strain-Specific, Hereditary, and AHR-Dependent Components

By Paul C. Boutros, Ivy D. Moffat, Allan B. Okey and Raimo Pohjanvirta

Abstract

Rat is a major model organism in toxicogenomics and pharmacogenomics. Hepatic mRNA profiles after treatment with xenobiotic chemicals are used to predict and understand drug toxicity and mechanisms. Surprisingly, neither inter- and intra-strain variability of mRNA abundances in control rats nor the heritability of rat mRNA abundances yet been established. We address these issues by studying five populations: the popular Sprague-Dawley strain, sub-strains of Long-Evans and Wistar rats, and two lines derived from crosses between the Long-Evans and Wistar sub-strains. Using three independent techniques – variance analysis, linear modelling, and unsupervised pattern recognition – we characterize extensive intra- and inter-strain variability in mRNA levels. We find that both sources of variability are non-random and are enriched for specific functional groups. Specific transcription-factor binding-sites are enriched in their promoter regions and these genes occur in “islands” scattered throughout the rat genome. Using the two lines generated by crossbreeding we tested heritability of hepatic mRNA levels: the majority of rat genes appear to exhibit directional genetics, with only a few interacting loci. Finally, a comparison of inter-strain heterogeneity between mouse and rat orthologs shows more heterogeneity in rats than mice; thus rat and mouse heterogeneity are uncorrelated. Our results establish that control hepatic mRNA levels are relatively homogeneous within rat strains but highly variable between strains. This variability may be related to increased activity of specific transcription-factors and has clear functional consequences. Future studies may take advantage of this phenomenon by surveying panels of rat strains

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3132743
Provided by: PubMed Central

Suggested articles

Citations

  1. (2007). A five-gene signature and clinical outcome in non-small-cell lung cancer.
  2. (2002). A geneexpression signature as a predictor of survival in breast cancer.
  3. (2004). affy–analysis of Affymetrix GeneChip data at the probe level.
  4. (2007). An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture,
  5. (2010). Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities.
  6. (2007). Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes.
  7. (2006). Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries.
  8. (2006). Background gene expression in rat kidney: influence of strain, gender, and diet. Toxicol Sci 94: 226–233. 1 9 .C e r u t t iC ,K u r d iM ,B r i c c aG ,H o d r o jW ,P a u l t r eC ,e ta l
  9. (2003). Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure.
  10. (2006). Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD
  11. (2006). dbZach: A MIAMEcompliant toxicogenomic supportive relational database. Toxicol Sci 90: 558–568. mRNA Levels
  12. (2004). Detection of functional DNA motifs via statistical over-representation.
  13. (2009). Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHRnull mice.
  14. (2002). Empirical bayes methods and false discovery rates for microarrays.
  15. (2002). Expression profiling identifies strain-specific changes associated with ethanol withdrawal in mice.
  16. (2006). Gene expression profiling in cervical cancer: an exploration of intratumor heterogeneity.
  17. (2004). Genetic analysis of genome-wide variation in human gene expression.
  18. (2004). Genetic inheritance of gene expression in human cell lines.
  19. (2003). Genetics of gene expression surveyed in maize, mouse and man.
  20. (2006). Genetics of global gene expression.
  21. (2004). Genome sequence of the Brown Norway rat yields insights into mammalian evolution.
  22. (2008). Genome-wide effects of acute progressive feed restriction in liver and white adipose tissue.
  23. (2002). Genomic interrogation of mechanism(s) underlying cellular responses to toxicants.
  24. (2006). Global variation in copy number in the human genome.
  25. (2003). GoMiner: a resource for biological interpretation of genomic and proteomic data.
  26. (2005). Hepatic gene expression changes throughout the day in the Fischer rat: implications for toxicogenomic experiments.
  27. (2004). Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour.
  28. (2005). Impact of genomics on research in the rat.
  29. (2004). JASPAR: an open-access database for eukaryotic transcription factor binding profiles.
  30. Kwitek AE (2002) Rat genetics: attaching physiology and pharmacology to the genome.
  31. (2003). Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments.
  32. (2007). Literaturebased compound profiling: application to toxicogenomics.
  33. (2005). Mapping determinants of human gene expression by regional and genome-wide association.
  34. (1990). Mechanism of action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
  35. (1994). Molecular biology of the aromatic hydrocarbon (dioxin) receptor.
  36. (2003). Natural variation in human gene expression assessed in lymphoblastoid cells.
  37. (2008). Patterns of dioxin-altered mRNA expression in livers of dioxin-sensitive versus dioxin-resistant rats.
  38. (1999). Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains.
  39. (1998). Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxinresistant rat strain.
  40. (2001). Project normal: defining normal variance in mouse gene expression.
  41. (2004). Sandelin A
  42. (2003). Sex-dependent gene expression and evolution of the Drosophila transcriptome.
  43. (2007). Significant gene content variation characterizes the genomes of inbred mouse strains.
  44. (2008). Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories.
  45. (2003). Summaries of Affymetrix GeneChip probe level data.
  46. (1999). The AH receptor and a novel gene determine acute toxic responses to TCDD: segregation of the resistant alleles to different rat lines.
  47. (2007). The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems.
  48. (2006). The contributions of normal variation and genetic background to mammalian gene expression.
  49. (2001). The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster.
  50. (2000). The PAS superfamily: sensors of environmental and developmental signals.
  51. (2003). The UCSC Genome Browser Database.
  52. (2006). Toxicogenomics strategies for predicting drug toxicity.
  53. (2008). Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse.
  54. (2005). Unsupervised pattern recognition: an introduction to the whys and wherefores of clustering microarray data.
  55. (2005). Variation in the hepatic gene expression in individual male Fischer rats. Toxicol Pathol 33: 102–110. 3 9 . B o u t r o sP C ,L a uS K ,P i n t i l i eM

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.